These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22492660)

  • 41. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance.
    Durán Pacheco G; Hattendorf J; Colford JM; Mäusezahl D; Smith T
    Stat Med; 2009 Oct; 28(24):2989-3011. PubMed ID: 19672840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Marginal structural models and causal inference in epidemiology.
    Robins JM; Hernán MA; Brumback B
    Epidemiology; 2000 Sep; 11(5):550-60. PubMed ID: 10955408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis.
    Rücker G; Schwarzer G; Carpenter JR; Binder H; Schumacher M
    Biostatistics; 2011 Jan; 12(1):122-42. PubMed ID: 20656692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive design: estimation and inference with censored data in a semiparametric model.
    Shen Y; Cheng Y
    Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.
    Cole SR; Stuart EA
    Am J Epidemiol; 2010 Jul; 172(1):107-15. PubMed ID: 20547574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies.
    Shintani AK; Girard TD; Eden SK; Arbogast PG; Moons KG; Ely EW
    Crit Care Med; 2009 Nov; 37(11):2939-45. PubMed ID: 19770737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses.
    Austin PC
    Int J Biostat; 2009 Apr; 5(1):Article 13. PubMed ID: 20949126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
    Austin PC
    Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity analysis for unmeasured confounding in a marginal structural Cox proportional hazards model.
    Klungsøyr O; Sexton J; Sandanger I; Nygård JF
    Lifetime Data Anal; 2009 Jun; 15(2):278-94. PubMed ID: 19109770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Weighted analyses for cohort sampling designs.
    Gray RJ
    Lifetime Data Anal; 2009 Mar; 15(1):24-40. PubMed ID: 18712477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of instrumental variable method using Cox proportional hazard model in epidemiological studies.
    Uddin MJ; Ahammed T; Kabir AZMH
    MethodsX; 2023; 10():102211. PubMed ID: 37234936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study.
    Edessa D; Likisa J
    PLoS One; 2015; 10(9):e0137492. PubMed ID: 26348618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.
    Latimer NR; Abrams KR; Lambert PC; Morden JP; Crowther MJ
    Stat Methods Med Res; 2018 Mar; 27(3):765-784. PubMed ID: 27114326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating relative risks in multicenter studies with a small number of centers - which methods to use? A simulation study.
    Pedroza C; Truong VTT
    Trials; 2017 Nov; 18(1):512. PubMed ID: 29096682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncology.
    Cottone F; Deliu N; Collins GS; Anota A; Bonnetain F; Van Steen K; Cella D; Efficace F
    Qual Life Res; 2019 May; 28(5):1315-1325. PubMed ID: 30659449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length of stay.
    Samore MH; Shen S; Greene T; Stoddard G; Sauer B; Shinogle J; Nebeker J; Harbarth S
    Med Care; 2007 Oct; 45(10 Supl 2):S108-15. PubMed ID: 17909368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies.
    van der Net JB; Janssens AC; Eijkemans MJ; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Eur J Hum Genet; 2008 Sep; 16(9):1111-6. PubMed ID: 18382476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data.
    Burne RM; Abrahamowicz M
    Stat Methods Med Res; 2019 Feb; 28(2):357-371. PubMed ID: 28835193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Untangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa.
    Elul B; Wools-Kaloustian KK; Wu Y; Musick BS; Nuwagaba-Biribonwoha H; Nash D; Ayaya S; Bukusi E; Okong P; Otieno J; Wabwire D; Kambugu A; Yiannoutsos CT
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):324-32. PubMed ID: 26910499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.